This hypothesis is supported by previous studies on CXCL1 expression in the MMTV-PyVmT transgenic mouse model, where CXCL1 functioned to recruit myeloid immune suppressor cells that enhanced survival and invasion of mammary tumors. This evidence concerns the gene CXCL1 and breast cancer.